Clincosm LogoSign in Get a demo

Hematologic Malignancies

Showing NaN - NaN of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancies Trial in Australia, United States (APG-2575)

Recruiting
  • Hematologic Malignancies
  • Jacksonville, Florida
  • +4 more
Aug 12, 2022

Hematologic Malignancies Trial in China, United States (GFH009)

Recruiting
  • Hematologic Malignancies
  • New Orleans, Louisiana
  • +16 more
Aug 2, 2022

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Solid Tumor, Hematologic Malignancies Trial in United States (LGX818)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +12 more
Mar 1, 2021

Hematologic Malignancies Trial in United States (IPI-145 (duvelisib))

Terminated
  • Hematologic Malignancies
  • IPI-145 (duvelisib)
  • New York, New York
  • +3 more
Mar 15, 2021

Hematologic Malignancies Trial in Houston (CA-18C3)

Completed
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
Feb 12, 2021

Hematologic Malignancies Trial in Houston (BPX-501, AP1903)

Withdrawn
  • Hematologic Malignancies
  • Houston, Texas
    MD Anderson Cancer Center
Oct 1, 2020

Cancer, Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Denosumab, Zoledronic acid, Placebo to Denosumab)

Completed
Has Results
  • Cancer
  • +5 more
  • Tucson, Arizona
  • +308 more
Mar 19, 2020

Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies Trial in Houston (Cyclophosphamide, Fludarabine,

Completed
Has Results
  • Blood Stem Cell Transplant Failure
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 12, 2020

Cancer, Hematologic Malignancies Trial in Houston (TAPA-pulsed DC vaccine)

Withdrawn
  • Cancer
  • Hematologic Malignancies
  • TAPA-pulsed DC vaccine
  • Houston, Texas
    MD Anderson Cancer Center
Oct 10, 2019

Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)

Terminated
Has Results
  • Solid Tumor
  • Hematologic Malignancies
  • Birmingham, Alabama
  • +55 more
May 28, 2019

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome, Hematologic Malignancies Trial in France, United States (AG881)

Completed
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Aurora, Colorado
  • +5 more
Mar 6, 2019

Hematologic Malignancies Trial in Houston (Tezacitabine (FMdC))

Completed
  • Hematologic Malignancies
  • Tezacitabine (FMdC)
  • Houston, Texas
    UT MD Anderson Cancer Center
Oct 31, 2018

Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Hematologic Malignancies
  • San Francisco, California
  • +4 more
May 15, 2018

Cancer, Hematologic Malignancies, Leukemia Trial in Stony Brook, Cleveland, Houston (Arm 1- Dose Escalation, Arm 2- Dose

Completed
  • Cancer
  • +3 more
  • Arm 1- Dose Escalation
  • Arm 2- Dose Expansion
  • Stony Brook, New York
  • +2 more
Nov 1, 2017

Hematologic Malignancies Trial in Houston (biological, drug, procedure, radiation)

Terminated
Has Results
  • Hematologic Malignancies
  • Campath 1H
  • +4 more
  • Houston, Texas
  • +1 more
Sep 20, 2016

Invasive Fungal Infections, Hematologic Malignancies Trial in Houston (Posaconazole, ABLC)

Completed
Has Results
  • Invasive Fungal Infections
  • Hematologic Malignancies
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 22, 2016

Hematologic Malignancies, Leukemia Trial in Tampa, Houston (Triciribine)

Completed
  • Hematologic Malignancies
  • Leukemia
  • Tampa, Florida
  • +1 more
Aug 6, 2016

Advanced Solid Tumors, Hematologic Malignancies Trial in United States (IXAZOMIB)

Completed
Has Results
  • Advanced Solid Tumors
  • Hematologic Malignancies
  • Fairway, Kansas
  • +3 more
May 3, 2016

Hematologic Malignancies, Leukemia, MDS Trial in United States (ridaforolimus)

Completed
  • Hematologic Malignancies
  • +4 more
  • Chicago, Illinois
  • +7 more
Aug 18, 2015

Hematologic Malignancies Trial in Baltimore, New York, Houston (IPI-493)

Terminated
  • Hematologic Malignancies
  • Baltimore, Maryland
  • +2 more
Apr 14, 2015

Hematologic Malignancies Trial in Italy, United States (PF-04449913)

Completed
  • Hematologic Malignancies
  • La Jolla, California
  • +5 more
Dec 8, 2013

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

Hematologic Malignancies Trial in Houston (Cloretazine, Fludarabine)

Completed
  • Hematologic Malignancies
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 27, 2012

Solid Tumors, Hematologic Malignancies, Myelodysplastic Syndrome Trial in Houston, Madison, Singapore (SB939, Azacitidine)

Completed
  • Solid Tumors
  • +2 more
  • Houston, Texas
  • +4 more
Apr 19, 2012